AC Immune SA IPO Research Information

AC Immune SA IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on AC Immune SA, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
AC Immune SA	ACIU - NASDAQ	$11.00-$13.00	$11.00	$14.11	6 million	9/23/2016
Underwriter(s): Credit Suisse, Jefferies, Leerink Partners
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2016-05-31 Terms Added 2016-09-13 Revised Terms 2016-09-21

AC Immune SA Quote & Chart - Click for current quote - ACIU

About AC Immune SA (adapted from AC Immune SA prospectus):
They are a clinical stage biopharmaceutical company leveraging our two proprietary technology platforms to discover, design and develop novel, proprietary medicines for prevention, diagnosis and treatment of neurodegenerative diseases associated with protein misfolding.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ACIU" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.